{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:55:48Z","timestamp":1791860148716,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1059660 and 1156072"],"award-info":[{"award-number":["1059660 and 1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jad.2018.10.083","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T01:59:50Z","timestamp":1538791190000},"page":"1043-1051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8038-4643","authenticated-orcid":false,"given":"Pernille Kempel","family":"Ellegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Wentzer","family":"Licht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-6352","authenticated-orcid":false,"given":"Ren\u00e9 Ernst","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia May","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5554-6946","authenticated-orcid":false,"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Enghusen","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-7211","authenticated-orcid":false,"given":"Mohammadreza","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie Thuroee","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.10.083_bib0001","series-title":"Capter 6: Mood Disorders, Mixed Episode","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.jad.2018.10.083_bib0002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0924-9338(97)86748-X","article-title":"DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. European psychiatry","volume":"13","author":"Amorim","year":"1998","journal-title":"J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.jad.2018.10.083_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","article-title":"N-Acetylcysteine\u2013a safe antidote for cysteine\/glutathione deficiency","volume":"7","author":"Atkuri","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jad.2018.10.083_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1034\/j.1600-0447.2002.01404.x","article-title":"The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure","volume":"106","author":"Bech","year":"2002","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2018.10.083_bib0005","series-title":"Textbook of Biological psychiatry. Part 1: Basic principles","article-title":"Measurement Issues","author":"Bech","year":"2002"},{"key":"10.1016\/j.jad.2018.10.083_bib0006","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/10401230309085691","article-title":"Mood Stabilizers and treatment adherence in bipolar disorder: addressing adverse events","volume":"15","author":"Berk","year":"2003","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0007","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder\u2013a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0008","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","article-title":"The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial","volume":"135","author":"Berk","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.10.083_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1741-7015-10-91","article-title":"Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial","volume":"10","author":"Berk","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2018.10.083_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","article-title":"Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder","author":"Berk","year":"2007","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.jad.2018.10.083_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jad.2018.10.083_bib0012","first-page":"964","article-title":"Acetaminophen poisoning: a case report of the use of acetylcysteine","volume":"35","author":"D.","year":"1978","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.jad.2018.10.083_bib0013","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2018.10.083_bib0014","first-page":"294","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review","author":"Deepmala, Slattery","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2018.10.083_bib0015","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/14728220802517901","article-title":"N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility","volume":"8","author":"Dodd","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jad.2018.10.083_bib0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","article-title":"Glutathione pathways in the brain","volume":"384","author":"Dringen","year":"2003","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jad.2018.10.083_bib0017","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40345-018-0117-9","article-title":"Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)","volume":"6","author":"Ellegaard","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2018.10.083_bib0019","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.publhealth.22.1.167","article-title":"Selected statistical issues in group randomized trials","volume":"22","author":"Feng","year":"2001","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.jad.2018.10.083_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA: J. Am. Med. Assoc."},{"key":"10.1016\/j.jad.2018.10.083_bib0021","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/NDT.S166730","article-title":"Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA","volume":"14","author":"Greene","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2018.10.083_bib0022","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0023","series-title":"ECDEU Assessment Manual For Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.jad.2018.10.083_bib0024","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","article-title":"Critical role of brain-derived neurotrophic factor in mood disorders","volume":"45","author":"Hashimoto","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.jad.2018.10.083_bib0026","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-0327(01)00451-7","article-title":"Defining remission by cut off score on the MADRS: selecting the optimal value","volume":"72","author":"Hawley","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.10.083_bib0027","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jnr.10510","article-title":"Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons","volume":"71","author":"Himi","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jad.2018.10.083_bib0028","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s11064-007-9315-z","article-title":"Modulation of [3H]dopamine release by glutathione in mouse striatal slices","volume":"32","author":"Janaky","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jad.2018.10.083_bib0029","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.10.083_bib0031","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2018.10.083_bib0032","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.0006-341X.2000.00271.x","article-title":"The impact of restrictive entry criterion during the placebo lead-in period","volume":"56","author":"Landin","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2018.10.083_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/S0924-9338(99)80239-9","article-title":"The mini international neuropsychiatric interview","volume":"13","author":"Lecrubier","year":"1998","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1081\/BIP-100104194","article-title":"Accounting for dropout bias using mixed-effects models","volume":"11","author":"Mallinckrodt","year":"2001","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.jad.2018.10.083_bib0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","article-title":"N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects","volume":"13","author":"Minarini","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jad.2018.10.083_bib0036","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0037","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1179\/1351000215Y.0000000004","article-title":"N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study","volume":"20","author":"Prado","year":"2015","journal-title":"Redox Rep."},{"key":"10.1016\/j.jad.2018.10.083_bib0038","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40263-015-0272-9","article-title":"N-Acetyl Cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study","volume":"29","author":"Sarris","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2018.10.083_bib0039","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000327682","article-title":"Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study","volume":"17","author":"Schmaal","year":"2011","journal-title":"Eur. Addict. Res."},{"issue":"Suppl 20","key":"10.1016\/j.jad.2018.10.083_bib0040","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0042","series-title":"World Health Organization, Regional Office For Europe: Well-Being Mea- sures in Primary Health Care\u2013 the Depcare Project","article-title":"The use of well-being measures in primary health care \u2013 the Dep-Care project","author":"Staehr Johansen","year":"1998"},{"key":"10.1016\/j.jad.2018.10.083_bib0043","series-title":"Stata Statistical Software: Release 15","year":"2017"},{"key":"10.1016\/j.jad.2018.10.083_bib0044","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/clpt.2014.59","article-title":"Methods for measuring, enhancing, and accounting for medication adherence in clinical trials","volume":"95","author":"Vrijens","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jad.2018.10.083_bib0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.10.083_bib0046","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","article-title":"Molecular mechanisms of N-acetylcysteine actions","volume":"60","author":"Zafarullah","year":"2003","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718312886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718312886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:25:31Z","timestamp":1759022731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718312886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":45,"alternative-id":["S0165032718312886"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.10.083","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.10.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}